List of Tables
Table 1. Global Cell Viability Assays Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Human Cells
Table 3. Key Players of Microbial Cells
Table 4. Key Players of Animal Cells
Table 5. Global Cell Viability Assays Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Cell Viability Assays Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Cell Viability Assays Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Cell Viability Assays Market Share by Region (2017-2022)
Table 9. Global Cell Viability Assays Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Cell Viability Assays Market Share by Region (2023-2028)
Table 11. Cell Viability Assays Market Trends
Table 12. Cell Viability Assays Market Drivers
Table 13. Cell Viability Assays Market Challenges
Table 14. Cell Viability Assays Market Restraints
Table 15. Global Cell Viability Assays Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Cell Viability Assays Revenue Share by Players (2017-2022)
Table 17. Global Top Cell Viability Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2021)
Table 18. Ranking of Global Top Cell Viability Assays Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Cell Viability Assays Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell Viability Assays Product Solution and Service
Table 22. Date of Enter into Cell Viability Assays Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Cell Viability Assays Revenue Market Share by Type (2017-2022)
Table 26. Global Cell Viability Assays Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Cell Viability Assays Revenue Market Share by Type (2023-2028)
Table 28. Global Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Cell Viability Assays Revenue Share by Application (2017-2022)
Table 30. Global Cell Viability Assays Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Cell Viability Assays Revenue Share by Application (2023-2028)
Table 32. North America Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Cell Viability Assays Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Cell Viability Assays Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Cell Viability Assays Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Cell Viability Assays Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Cell Viability Assays Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Cell Viability Assays Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Cell Viability Assays Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Cell Viability Assays Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Cell Viability Assays Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Cell Viability Assays Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Cell Viability Assays Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Cell Viability Assays Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million)
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Cell Viability Assays Product
Table 65. Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Developments
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Cell Viability Assays Product
Table 70. Merck Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 71. Merck Recent Developments
Table 72. Bio-Rad Company Details
Table 73. Bio-Rad Business Overview
Table 74. Bio-Rad Cell Viability Assays Product
Table 75. Bio-Rad Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 76. Bio-Rad Recent Developments
Table 77. GE Company Details
Table 78. GE Business Overview
Table 79. GE Cell Viability Assays Product
Table 80. GE Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 81. GE Recent Developments
Table 82. Danaher Company Details
Table 83. Danaher Business Overview
Table 84. Danaher Cell Viability Assays Product
Table 85. Danaher Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 86. Danaher Recent Developments
Table 87. BD Company Details
Table 88. BD Business Overview
Table 89. BD Cell Viability Assays Product
Table 90. BD Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 91. BD Recent Developments
Table 92. PerkinElmer Company Details
Table 93. PerkinElmer Business Overview
Table 94. PerkinElmer Cell Viability Assays Product
Table 95. PerkinElmer Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 96. PerkinElmer Recent Developments
Table 97. Promega Company Details
Table 98. Promega Business Overview
Table 99. Promega Cell Viability Assays Product
Table 100. Promega Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 101. Promega Recent Developments
Table 102. Biotium Company Details
Table 103. Biotium Business Overview
Table 104. Biotium Cell Viability Assays Product
Table 105. Biotium Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 106. Biotium Recent Developments
Table 107. Abcam Company Details
Table 108. Abcam Business Overview
Table 109. Abcam Cell Viability Assays Product
Table 110. Abcam Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 111. Abcam Recent Developments
Table 112. Creative Bioarray Company Details
Table 113. Creative Bioarray Business Overview
Table 114. Creative Bioarray Cell Viability Assays Product
Table 115. Creative Bioarray Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 116. Creative Bioarray Recent Developments
Table 117. Biotek Instruments Company Details
Table 118. Biotek Instruments Business Overview
Table 119. Biotek Instruments Cell Viability Assays Product
Table 120. Biotek Instruments Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million)
Table 121. Biotek Instruments Recent Developments
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Viability Assays Market Share by Type: 2021 VS 2028
Figure 2. Human Cells Features
Figure 3. Microbial Cells Features
Figure 4. Animal Cells Features
Figure 5. Global Cell Viability Assays Market Share by Application: 2021 VS 2028
Figure 6. Pharmaceutical and Biotechnology Companies Case Studies
Figure 7. Academic and Research Institutes Case Studies
Figure 8. Hospital and Diagnostic Laboratories Case Studies
Figure 9. Others Case Studies
Figure 10. Cell Viability Assays Report Years Considered
Figure 11. Global Cell Viability Assays Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Cell Viability Assays Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Cell Viability Assays Market Share by Region: 2021 VS 2028
Figure 14. Global Cell Viability Assays Market Share by Players in 2021
Figure 15. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Cell Viability Assays Revenue in 2021
Figure 17. North America Cell Viability Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Cell Viability Assays Market Size Market Share by Type (2017-2028)
Figure 19. North America Cell Viability Assays Market Size Market Share by Application (2017-2028)
Figure 20. North America Cell Viability Assays Market Size Share by Country (2017-2028)
Figure 21. United States Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Cell Viability Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Cell Viability Assays Market Size Market Share by Type (2017-2028)
Figure 25. Europe Cell Viability Assays Market Size Market Share by Application (2017-2028)
Figure 26. Europe Cell Viability Assays Market Size Share by Country (2017-2028)
Figure 27. Germany Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Cell Viability Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Cell Viability Assays Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Cell Viability Assays Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Cell Viability Assays Market Size Share by Region (2017-2028)
Figure 37. China Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Cell Viability Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Cell Viability Assays Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Cell Viability Assays Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Cell Viability Assays Market Size Share by Country (2017-2028)
Figure 47. Mexico Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Cell Viability Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Cell Viability Assays Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Cell Viability Assays Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Cell Viability Assays Market Size Share by Country (2017-2028)
Figure 53. Turkey Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 57. Merck Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 58. Bio-Rad Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 59. GE Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 60. Danaher Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 61. BD Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 62. PerkinElmer Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 63. Promega Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 64. Biotium Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 65. Abcam Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 66. Creative Bioarray Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 67. Biotek Instruments Revenue Growth Rate in Cell Viability Assays Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed